G protein-coupled receptors (GPCRs) drive an array of important physiological functions and are the targets of nearly one-third of all FDA approved drugs. Large scale genomic initiatives are mapping the genetic diversity in GPCRs, however, a map of which GPCR genetic variants are associated with phenotypic variation and disease is lacking. Furthermore, the mechanistic basis of how the individual GPCR genetic variants regulate molecular function is also largely unknown. We performed a phenome-wide association analysis for 269 common protein-altering variants in 156 GPCRs and 275 phenotypes using data from 337,205 unrelated white British UK Biobank participants and identified 138 associations at a false discovery rate of 5%. We found a novel association between rs12295710 in MRGPRE, a member of the Mas-related receptor family involved in nociception, and migraine risk. We also identified an association between rs3732378, a missense mutation in the binding pocket of CX3CR1, and hypothyroidism. Five orphan GPCRs had eight genetic associations, highlighting novel biology for these receptors of unknown function. We found several associations between GPCR variants and food intake phenotypes, including an association between the variants in TAS2R38 known to affect the ability to taste phenylthiocarbamide and tea intake as well as a non-additive associations between variants in TAS2R19 and TAS2R31 and coffee and tea intake. Finally, we tested whether genetic variants in ADRB2 associated with immune cell amounts and pulmonary function affect downstream signaling pathways and found that two ADRB2 haplotypes are associated with differential signaling relative to the most common haplotype. Overall, this study provides a map of genetic associations for GPCR coding variants across a wide variety of phenotypes that can inform future drug discovery efforts targeting GPCRs.
1 Introduction G Protein Coupled Receptors (GPCRs) are allosteric molecular machines that detect extracellular messages, such as small molecules, peptides, light, or ions, and transmit a reciprocal signal into the cell. There are over 800 GPCRs in the human proteome, and they play key roles in diverse physiological functions and are the target of over a third of FDA approved medications (Katritch et al., 2013) . Interest from the pharmaceutical industry and basic science has fueled intensive study of GPCRs, yet there still exist many GPCRs for which the primary physiological function is unknown, and even for well studied receptors the full range of physiological impacts may not be known. Understanding the role of GPCRs is particularly relevant because their positioning on the cell surface make them relatively easy to target with drugs, making it realistic to translate an association into a medication.
The UK Biobank dataset contains genetic and phenotypic data for nearly 500,000 individuals and provides a unique opportunity to study the physiological impact of GPCRs by performing a phenome-wide association study (PheWAS) to identify associations between variants in GPCRs and diverse phenotypes such as immune cell measurements, vital signs, and disease risk (Sudlow et al., 2015) . A PheWAS focused on protein-altering variants in GPCRs can connect GPCRs to specific phenotypes and generate novel therapeutic hypotheses as they are likely candidates for causal variants (Altshuler et al., 2008) . We can also leverage the increasing number of GPCR protein structures and shared structural scaffold across the GPCR family to identify specific genetic variants that are likely to impact protein structure and explain the genetic associations. Additionally, while the vast array of GPCRs recognize a diverse set of extracellular signals, they share a common set of intracellular binding partners: G Proteins and arrestins (Venkatakrishnan et al., 2013) . G protein and arrestin coupling are directly measurable, providing insight into the molecular impact of GPCR variants.
In this study, we performed a PheWAS for 269 missense and protein-truncating variants in 156 GPCR genes across 275 phenotypes in the UK Biobank and identified 138 associations at a false discovery rate of 5%. The associations spanned 52 coding variants in 41 GPCRs and 46 quantitative or binary phenotypes and included both novel and previously reported associations. We identified five associations with binary phenotypes including an association between rs12295710 in MRGPRE, a gene whose paralogs are involved in nociception, and migraine (Dong et al., 2001) . The remaining 133 associations were between coding GPCR variants and quantitative phenotypes including immune cell measurements, body size, pulmonary function, food intake, and others. Five orphan receptors of unknown function had associations with quantitative traits including GPR35, a known drug target for inflammatory bowel disease and cardiovascular disease (Divorty et al., 2015) . We also found associations between variants in GPCR taste receptors known to affect bitter taste perception and self-reported tea and coffee intake. We tested genetic variants in ADRB2 associated with several phenotypes for effects on downstream signaling pathways and identified two ADRB2 haplotypes with differential signaling relative to the most frequent ADRB2 haplotype. This study links coding variation in GPCRs to a range of diverse phenotypes and identifies novel biology for this important class of drug targets.
Results

GPCR genetic associations across 275 phenotypes
To assess the impact of genetic variation in GPCRs on disease risk and other phenotypes, we performed genetic association analyses between GPCR variants and phenotypes for 337,205 individuals of unrelated white British ancestry in the UK Biobank (see Methods for description). Beginning with a list of 226 non-olfactory human GPCRs, we identified 251 missense and 18 protein-truncating variants in 156 human GPCR genes that were genotyped in the UK Biobank arrays, passed quality control filters (Methods), and had minor allele frequency (MAF) greater than 1% (Table S1 ). We tested for associations between these 269 variants and 146 quantitative phenotypes with at least 3,000 observations and 129 binary phenotypes with at least 2,000 cases in the studied cohort (Methods, Table S1 ). The quantitative phenotypes include continuous or ordinal phenotypes such as weight, waist size, and forced expiratory volume. The binary phenotypes include the presence or absence of health conditions such as hyperthyroidism, migraine, or lung cancer. Due to power differences between quantitative and binary phenotype association tests, we corrected for multiple hypothesis testing separately for the quantitative and binary phenotypes using the Benjamini-Yekutieli (BY) procedure at FDR rate of 5%. Overall, we identified 52 coding variants in 41 GPCRs that were associated with at least one of 46 quantitative or binary phenotypes for a total of 138 associations (Table S2 ).
Taking advantage of GPCRs sharing a common fold, we annotated the tested variants with across-family conservation scores, GPCR functional regions, and PolyPhen-2 pathogenicity scores (Methods) (Adzhubei et al., 2010; Pándy-Szekeres et al., 2018; Venkatakrishnan et al., 2013) . We compared the variants with and without significant associations to 86,601 rare protein-altering GPCR variants from gnomAD (Karczewski et al., 2019) (MAF<1%) and 318 GPCR variants reported in ClinVar (Landrum et al., 2018) and found that both the significant and non-significant UK Biobank variants had significantly lower PolyPhen-2 scores than the ClinVar and rare gnomAD GPCR variants (Wilcoxon, p<1x10 -5 ), consistent with the fact that the GPCR variants tested here are common (MAF > 1%) variants (Figure S1a-d, Table S3 ). Interestingly, there was not a significant difference between the UK Biobank variants with or without significant associations (Wilcoxon, p=0.69) suggesting that differences with other reference datasets have more to do with ascertainment of GPCR common variants in UK Biobank. We also compared family conservation scores for variants in class A GPCRs and found that the conservation scores generally agreed between the different variant sets except that ClinVar variants had higher conservation scores than gnomAD rare variants (Wilcoxon, p=3.8x10 -6 ) and variants without significant associations had lower conservation scores than ClinVar variants (Wilcoxon, p=0.013, Figure S1e , Table S3 ). Among the 52 variants with significant associations, we identified eight variants with associations that have PolyPhen-2 scores greater than 0.9, four variants located in the ligand binding pocket, and two variants located in the intracellular coupling interface (Table 1) . For instance, we identified an association between rs3732378 (p.Thr280Met, MAF=17.3%) in CX3CR1 and hypothyroidism (p=1.3x10 -7 , OR=1.07, 95% CI: 1.05-1.10). rs3732378 has a PolyPhen-2 score of 0.774 and is located in the binding pocket of CX3CR1. This GPCR is the sole receptor for the ligand fractalkine (CX3CL1), a chemokine with anti-apoptotic properties that has been implicated in oncogenesis (Pinato and Mauri, 2014; Rosen and Privalsky, 2011) . We also identified associations between rs3732378 and monocyte counts, monocyte percentages, and lymphocyte counts (Table S2) , consistent with previous studies (Astle et al., 2016) . Expression of CX3CR1 is upregulated in the absence of triiodothyronine (T3) by thyroid receptors TRα1 and TRβ1 with mutations observed in human hepatocellular carcinoma suggesting that thyroid receptors may regulate CX3CR1 in some circumstances (Chan and Privalsky, 2009 ). Overall, these results indicate that although the common variants tested are generally not predicted to have a high impact on proteins, as is expected for common variants, they associate with phenotypic variation and some indeed have large predicted impact on proteins (Table 1) . Table 1 . GPCR variants with significant associations and PolyPhen-2 scores greater than 0.9 or known functional annotations. "Number of Associations" indicates the number of significant associations identified for each variant in this study across both quantitative and binary phenotypes.
Associations with binary medical phenotypes
We identified 5 associations between GPCR variants and binary phenotypes (BY-adjusted p < 0.05, Table 2 , Table S2 ). We identified a novel association between rs12295710 (p.Gly15Ser, MAF=47.1%) in MRGPRE, a member of the Mas-related receptor family, and migraine (p=3.8x10 -8 , OR=1.07, 95% CI: 1.05-1.10). Neither this variant nor other variants in linkage disequilibrium (LD) with it (R 2 >0.8, British in England and Scotland (GBR)) have been previously reported as associated with migraine in the GWAS Catalog, in a meta-analysis of migraine GWAS including 375,000 individuals, or in a study of broadly-defined headaches in the UK Biobank (Buniello et al., 2019; International Headache Genetics Consortium et al., 2016; Meng et al., 2018) . Though the endogenous ligand of MRGPRE is unknown, Mas-related receptors are expressed in nociceptive sensory neurons and play a role in pain response. MRGPRE is expressed throughout the brains of macaque, mouse, and human including sensory neurons in mouse (Dong et al., 2001; Manteniotis et al., 2013; Zhang et al., 2005) . Suggestive associations between variants in MRGPRE and white matter mean diffusivity and brain lesion distribution in multiple sclerosis have been reported indicating a possible role for MRGPRE in neurological disorders (Gourraud et al., 2013; Raffield et al., 2015) .
We found an association between rs2234919 (p.Pro52Thr, MAF=5.5%) in the Thyroid Stimulating Hormone Receptor (TSHR) and hyperthyroidism (p=3.6x10 -7 , OR=0.74, 95% CI: 0.66-0.83). Previous studies have found conflicting evidence regarding the association between rs2234919 and hyperthyroidism (Pujol-Borrell et al., 2015) , and the variant is flagged as likely benign in ClinVar consistent with our finding that the minor allele lowers hyperthyroidism risk.
We also identified an association between rs72703203 (p.Arg2015Lys, MAF=4.2%) in CELSR2 and high cholesterol (p=1.5x10 -17 , OR=0.85, 95% CI: 0.81-0.88). Variants in or near CELSR2 have been previously associated with cholesterol, response to statins, lipoprotein-associated phospholipase A2 activity, and coronary artery disease (Arvind et al., 2014; Grallert et al., 2012; Ma et al., 2010; Postmus et al., 2014; van der Harst and Verweij, 2018) . While rs72703203 is not in high LD with previously reported variants ( Figure S2 ), it is not significant (p=0.21) in a model that includes rs12740374, a 3' UTR variant in SORT1 proposed as the causal variant in this region (Musunuru and Kathiresan, 2019) . We identified an association between rs2274911 (p.Pro91Ser, MAF=26.7%) in GPRC6A and prostate cancer (p=8.2x10 -8 , OR=1.12, 95% CI: 1.07-1.17). rs2274911 is in LD with rs339331 (R 2 =0.846, GBR) which has previously been associated with prostate cancer, and rs2274911 is not significant in a model that includes rs339331 as a covariate (p=0.47) (Hoffmann et al., 2015; Takata et al., 2010; Wang et al., 2015) . 
Associations with quantitative phenotypes
We identified 133 quantitative phenotype associations for 49 protein-altering variants in 38 genes and 41 distinct phenotypes (BY-adjusted p < 0.05, Figure 1A -B, Table S2 ). 48 of these associations are present in this GWAS Catalog or in LD (R 2 >0.8, GBR) with GWAS Catalog associations (Buniello et al., 2019) . We identified novel associations for variants in three GPCRs with no entries in the GWAS catalog: rs7570797 in PROKR1 (p.Ser40Gly, MAF=4.6%) was associated with platelet crit (p=1.59x10 -7 , =-0.023, 95% CI: -0.032 --0.015); rs1466684 in P2RY13 (p.Thr179Met, MAF=18.0%) was associated with neutrophil count (p=1.68x10 -6 , =0.016, 95% CI: 0.0094-0.023); and rs4274188 in MRGPRX3 (p.Asn169Asp, MAF=23.4%) was associated with standing height (p=7.69x10 -6 , =0.0090, 95% CI: 0.0051-0.013). We stratified the significant quantitative phenotype associations into the following phenotype categories (where n indicates the number of phenotypes with at least one association for each category): immune cell measurements (n=17), body size (n=6), lung function (n=6), food intake (n=4), physical ability (n=3), urine biomarkers (n=2), vital signs (n=2), and intelligence (n=1) ( Table  S1 ). We describe these associations in the sections below. 
Genetic variation in orphan GPCRs associated with quantitative phenotypes
The 269 variants tested for associations included 44 variants in 26 orphan GPCRs whose ligands and function are generally unknown (Tang et al., 2012) . We identified quantitative phenotype associations for variants in five orphan receptors (Table 3) . We found associations between rs3749171 in GPR35 (p.Thr139Met, MAF=18.2%) and monocyte count (p=7.5x10 -17 , =-0.024, 95% CI: -0.031 --0.019) and monocyte percentage (p=5.7x10 -8 , =-0.25, 95% CI: -0.016 --0.034). rs3749171 is in LD with the 5' UTR variant rs34236350 (R 2 =1, GBR) that has previously been reported as associated with monocyte count ( Figure S3 ) (Astle et al., 2016) . rs3749171 is in high LD with the intron variant rs4676410 (R 2 =0.82, GBR), and these two variants have previously been associated with ankylosing spondylitis, ulcerative colitis/inflammatory bowel disease, and pediatric autoimmune diseases ( Figure S3 ) (Ellinghaus et al., 2013; (igas) and Venkateswaran et al., 2018) . We also found associations between rs6437353 (p.Arg13His, MAF=45.6%) and mean platelet (thrombocyte) volume (p=2.8x10 -9 , =-0.021, 95% CI: -0.028 --0.014) and rs3749172 (p.Ser294Arg, MAF=42.6%) and monocyte count (p=2.6x10 -8 , =0.013, 95% CI: 0.0084-0.017). These variants are not in LD with rs3749171 or rs34236350 ( Figure S3 ), and neither these variants nor variants in LD with them have been previously reported as associated with these phenotypes in the GWAS Catalog (Buniello et al., 2019) .
We found associations for missense variants in orphan GPCRs GPR146, GPR20, GPR45, and GPR78 as well (Table 3) . The association between rs34591516 (p.Gly313Ser, MAF=4.6%) in GPR20 and diastolic blood pressure (p=1.8x10 -6 , =0.028, 95% CI: 0.017-0.04) agrees with a previous study that found the same variant associated with diastolic and systolic blood pressure (CHARGE-Heart Failure Consortium et al., 2016) . We find that rs9685931 (p.Arg342His, MAF=11.3%) in GPR78 is associated with standing height (p=1.1x10 -6 , =-0.012, 95% CI: -0.0077 --0.017). A different variant in the 3' UTR of GPR78, rs3775887, is in weak LD with rs9685931 (LD=0.18, GBR) and has previously been associated with FVC. Overall these associations indicate potential functions or relevant pathways for these orphan GPCRs. Genetic variation in GPCRs associated with food intake
We identified 12 associations between coding variants in GPCRs and food intake phenotypes. We found that variants in several taste receptors were associated with either coffee or tea intake (Table 4 ). Variants in the bitter taste receptor genes TAS2R19, TAS2R31, and TAS2R42 were associated with coffee intake, though the variants in TAS2R19 and TAS2R31 are in high LD (R 2 =0.9, GBR). rs10772420 (p.Arg299Cys, MAF=46.8%) in TAS2R19 has been shown to affect perception of bitterness, though it is unclear whether rs10772420, rs10845295 (p.Arg35Trp, MAF=48.6%) in TAS2R31, or a different variant is causal (Hayes et al., 2015 (Hayes et al., , 2011 . We also found associations between variants in the taste receptors TAS2R19, TAS2R31, TAS2R38, TAS2R42, and TAS2R7 and tea intake. The same variants in TAS2R19 and TAS2R31 that are in high LD and were associated with coffee intake are also associated with tea intake. The variants in TAS2R7 and TAS2R42 associated with tea intake are in moderate LD (R 2 =0.59, GBR). The variants in TAS2R38 that are associated with tea intake are in high LD and are known to affect the ability to taste phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP) ( Figure S4 ) (Kim, 2003; Risso et al., 2016) . The ability to taste PTC follows a dominant model of inheritance where the alternate "taster" allele C is dominant to the "non-taster" reference T allele for rs10246939 (Kim, 2003) . We therefore fit additive and genotypic models for tea intake and the variants in TAS2R38 to test whether the observed association with tea intake is dominant. Interestingly, we found that the association between variants in TAS2R38 and tea intake is consistent with an additive effect where each additional copy of the taster C allele is associated with increased tea intake (Figure 2A ). We did find evidence, however, that the association between rs10772420 in TAS2R19 and coffee intake is non-additive, where only one copy of the alternate allele accounts for the majority of the decrease in coffee intake ( Figure  2B ). We found weaker evidence that the association between variants in TAS2R19 and tea intake is non-additive, where one copy of the alternate alleles accounts for most of the increase in tea intake ( Figure 2C ). As noted above, rs10772420 is in LD with the rs10845295 in TAS2R31 (0.895, GBR). Overall, we identified three independent associations between variants in taste receptors and tea intake and two independent associations for coffee intake.
We also observed two associations between non-taste related GPCRs and self-reported food intake. We found that rs1800437 (p.Glu354Gln, MAF=19.4%) in GIPR is associated with fresh fruit intake (p=4.2x10 -9 , =0.017, 95% CI: 0.011-0.023). GIP-R is a receptor of gastric inhibitory polypeptide (GIP), which stimulates insulin release in the presence of elevated glucose (Dupre et al., 1973) . Mice lacking GIP-R exhibit higher blood glucose levels and impaired initial insulin response following oral glucose load (Miyawaki et al., 1999) . A previous pharmacological study of GIP-R found that there is a marked decrease in basal GIP-R signaling for the alternate rs1800437 allele compared to WT (Fortin et al., 2010) . We also identified several other associations for rs1800437 in GIPR (Figure 1b ) that agree with reported associations in the GWAS Catalog including associations with body mass index, weight, waist circumference, and hip circumference, though the reported association with fresh fruit intake has not been previously reported (Buniello et al., 2019) . We also found that the splice donor variant rs274624 (MAF=37.0%) in GRM3 is associated with cereal intake (p=2.1x10 -6 , =-0.011, 95% CI: -0.015 --0.0064). GRM3 encodes a metabotropic glutamate receptor that is involved in brain function.
Missense variants in GRM3 have been previously associated with cognitive performance and self-reported math ability and non-coding variants near GRM3 have been associated with several cognitive and psychiatric phenotypes including schizophrenia and neuroticism (23andMe Research Team et al., 2018; Buniello et al., 2019) . A non-coding variant near GRM3 has also been associated with body mass index, but no associations between variants in or near GRM3 and food intake have been reported previously (Kichaev et al., n.d.) . These results demonstrate that genetic variation in GPCRs can be linked to food intake using self-reported intake measurements in a population biobank. Tea intake 6.4x10 -9 -0.021 -0.028 --0.014 Table 4 . Associations between variants in taste receptors and coffee or tea intake. Figure 2 . -log10p-values and effect sizes for additive (white background) and genotypic (grey background) models of association between (a) rs10246939 in TAS2R38 and tea intake, (b) rs10772420 in TAS2R19 and coffee intake, and (c) rs10772420 in TAS2R19 and tea intake. The genotypic model includes separate terms for heterozygous and homozygous alternate genotypes. Red boxes indicate non-additive effects. AIC is the difference in AIC between the two models (genotypic minus additive).
Genetic variation in ADRB2 alters arrestin signaling
We identified associations between three missense variants in ADRB2, the β2 adrenergic receptor, and immune cell counts and percentages as well as forced expiratory volume in 1second (FEV1) and peak expiratory flow (PEF) ( Table 5 ). Several of these associations have been reported previously in the GWAS Catalog or are in LD with reported associations, though associations between rs1800888 (p.Thr164Ile, MAF=1.5%) and eosinophil counts (p=5.6x10 -6 , =0.045, 95% CI: 0.026-0.065) and eosinophil percentage (p=4.3x10 -8 , =0.061, 95% CI: 0.039-0.082) were not in the GWAS Catalog. Similarly, the associations between rs1042713 (p.Gly16Arg, MAF=36.1%) and immune cell counts and percentages were not in the GWAS Catalog or in LD with associations in the GWAS Catalog (Table 5 ) (Buniello et al., 2019) . Since rs1042713 and rs1042714 are in moderate LD (R 2 =0.469, GBR), we fit models for eosinophil counts, eosinophil percentage, monocyte percentage, and neutrophil count using all three variants in ADRB2. For all four phenotypes, only one of rs1042713 and rs1042714 were significant (p<0.05) indicating that these two variants likely do not have independent effects on these immune cell phenotypes. rs1800888 remained significant (p<0.05) conditioned on both rs1042713 and rs1042714 for eosinophil counts and percentages.
To further explore how genetic variation in ADRB2 might impact the function of the receptor, we assayed cAMP signaling, which is downstream of Gs, and -arrestin-1 and -arrestin-2 recruitment for the RQT, GET, GQI, and GQT ADRB2 haplotypes upon stimulation with the endogenous ligands epinephrine (epi) and norepinephrine (norepi). We refer to the ADRB2 haplotypes by the residues at the 3 variable positions; for instance, the most common haplotype is RQT where rs1042713 codes for arginine (Arg16Gly), rs1042714 codes for glutamine (Gln27Glu), and rs1800888 codes for threonine (Thr164Ile). We found that two of the haplotypes displayed significantly different signaling profiles than the most frequent haplotype RQT. The GET haplotype retained full arrestin recruitment but significantly affected Gs signaling; for epi, GET has a decreased pEC50 in the cAMP assay (p=0.02, Tukey's test), indicating that a higher concentration of ligand is required to induce the same level of signaling through cAMP ( Figure S5 , Table S4 ). Meanwhile, the GQI haplotype displayed decreased arrestin pEC50 and full Gs signaling relative to RQT (p < 0.004, Tukey's test). 
Discussion
This study provides a systematic catalog of associations between coding variants in GPCRs and 275 diverse phenotypes in the UK Biobank. We replicated known associations between variants associated with disease risk and quantitative phenotypes and identified novel associations that in some cases indicate novel functions for GPCRs. The association between rs12295710 in MRGPRE and migraine is particularly interesting given that the genes in this family play a role in sensing pain (Dong et al., 2001) . We found that rs3749171 in GPR35 is associated with monocyte counts and percentage and is in LD withGPR35 variants associated with ankylosing spondylitis, inflammatory bowel disease, and pediatric autoimmune diseases (refs above) . Interestingly, we also found a novel association between rs3749172 in GPR35 and monocyte counts, though this variant does not appear to be in LD with loci previously associated with diseases. The novel associations between GPCR taste receptors and selfreported tea and coffee intake demonstrate the utility of questionnaire data in population biobanks, even for relatively difficult-to-estimate phenotypes like food intake.
We found that the GET ADRB2 haplotype had decreased Gs signaling (as measured by cAMP levels) relative to the RQT haplotype and that the GQI haplotype had decreased arrestin recruitment relative to the RQT haplotype. The observed genetic association between decreased forced expiratory volume and the rs1800888 allele that codes for isoleucine and our results showing that GQI has decreased arrestin signaling might inform the role of B2AR in pulmonary function. Since arrestin recruitment induces B2AR desensitization, and, somewhat paradoxically, B2AR agonist activity is required for the development of asthma in mouse models, it is possible that the GQI haplotype may decrease lung function by reducing agonistinduced B2AR desensitization (Moore et al., 2007; Thanawala et al., 2013) . It is also possible, however, that the acute differences observed in these experiments may differ from long-term effects of differential signaling associated with genetic variants.
The genetic associations reported here link GPCRs to phenotypes and will be useful for assessing the function of GPCRs and potential effects of modulating these genes with therapeutics. Future studies utilizing exome or genome sequencing that can better ascertain rare variants in these genes will likely identify new associations that are not observed for common variants that have faced stronger selective pressure. In particular, studies that focus on populations with unique genetic histories such as founder populations or groups with high consanguinity offer an important opportunity to identify high-impact, rare variants in GPCRs that may have large impacts on phenotypic variation and disease risk.
Methods
Quality Control of Genotype Data
We used genotype data from UK Biobank dataset release version 2 for all aspects of the study.
To minimize the impact of cofounders and unreliable observations, we used a subset of individuals that satisfied all of the following criteria: (1) self-reported white British ancestry, (2) used to compute principal components, (3) not marked as outliers for heterozygosity and missing rates, (4) do not show putative sex chromosome aneuploidy, and (5) have at most 10 putative third-degree relatives. These criteria are reported by the UK Biobank in the file "ukb_sqc_v2.txt" in the following columns respectively: (1) "in_white_British_ancestry_subset,"
(2) "used_in_pca_calculation," (3) "het_missing_outliers," (4) "putative_sex_chromosome_aneuploidy", and (5) "excess_relatives." We removed 151,169 individuals that did not meet these criteria. For the remaining 337,205 individuals, we used PLINK v1.90b4.4 76 to compute the following statistics for each variant: (a) genotyping missingness rate, (b) p-values of Hardy-Weinberg test, and (c) allele frequencies (calculated separately for the two genotyping arrays used by the UK Biobank).
GPCR Variants UK Biobank Variant Annotation
Variants on the UK Biobank arrays were annotated using VEP version 87 and the GRCh37 reference (McLaren et al., 2016) . Protein truncating variants were predicted using the VEP LOFTEE plugin (https://github.com/konradjk/loftee). Linkage disequilibrium (LD) was calculated for the GBR British population from 1000 Genomes Phase 3 (Version 5) using LDmatrix from LDlink (https://ldlink.nci.nih.gov/) unless otherwise stated (Machiela and Chanock, 2015) .
GPCR Gene Definition
A list of GPCRs was obtained from the International Union of Basic and Clinical Pharmacology (IUPHAR) website in December 2017 (Table S1 ). This list excludes olfactory GPCRs.
GPCR Variant Filtering
We identified 1,263 coding variants in GPCRs that (1) were genotyped on the UK Biobank genotyping arrays, (2) not filtered out during quality control of the genotyping data, (3) were not in the major histocompatibility complex (chr6:28477797-33448354) (Church et al., 2011) , and (4) were annotated as one of the following variant types by VEP: missense_variant, frameshift_variant, stop_gained, splice_region_variant, splice_donor_variant, splice_acceptor_variant, stop_lost, inframe_deletion, start_lost, inframe_insertion, incomplete_terminal_codon_variant. We filtered the variants to include only those with minor allele frequency greater than 1% in the 337,205 white British subjects used in this study resulting in 269 variants in 156 genes (Table S1 ). 251 of the 269 variants are missense variants and the remaining 18 variants are predicted protein truncating variants.
GPCR Variant Annotation
86,601 rare protein-altering GPCR variants were obtained from from gnomAD (MAF<1%) and 318 GPCR variants were obtained from ClinVar (Karczewski et al., 2019; Landrum et al., 2018) . Family conservation scores were created using multiple sequence alignments from GPCRdb (Pándy-Szekeres et al., 2018) . The scores were defined as the frequency of the most common residue at each structurally equivalent position. PolyPhen-2 (Adzhubei et al., 2010) scores were obtained through the web portal at http://genetics.bwh.harvard.edu/pph2/bgi.shtml. Position of variants on the GPCR fold were determined using the multiple alignment from GPCRdb (Pándy-Szekeres et al., 2018) .
Phenotype Definitions
Hospital Record and Verbal Questionnaire
As previously described, we used the following procedure to define cases and controls for noncancer phenotypes (DeBoever et al., 2018) . For a given phenotype, ICD-10 codes (Data-Field 41202) were grouped with self-reported non-cancer illness codes from verbal questionnaires (Data-Field 20002) that were closely related. This was done by first creating a computationally generated candidate list of closely related ICD-10 codes and self-reported non-cancer illness codes, then manually curating the matches. The computational mapping was performed by calculating the token set ratio between the ICD-10 code description and the self-reported illness code description using the FuzzyWuzzy python package. The high scoring ICD-10 matches for each self-reported illness were then manually curated to ensure high confidence mappings. Manual curation was required to validate the matches because fuzzy string matching may return words that are similar in spelling but not in meaning. For example, to create a hypertension cohort the code description from Data-Field 20002 ("Hypertension") was mapped to all ICD-10 code descriptions and all closely related codes were returned ("I10: Essential (primary) hypertension" and "I95: Hypotension"). After manual curation code I10 would be kept and code I95 would be discarded. After matching ICD-10 codes and with self-reported illness codes, cases were identified for each phenotype using only the associated ICD-10 codes, only the associated self-reported illness codes, or both the associated ICD-10 codes and self-reported illness codes.
Family History
We used data from Category 100034 (Family history -Touchscreen -UK Biobank Assessment Centre) to define "cases" and controls for family history phenotypes. This category contains data from the touchscreen questionnaire on questions related to family size, sibling order, family medical history (of parents and siblings), and age of parents (age of death if died). We focused on Data Coding 20107: Illness of father and 20110: Illness of mother.
Genetic Association Analyses
Quantitative phenotypes
We identified 146 quantitative phenotypes with at least 3,000 observations among the 337,205 white British subjects in the UK Biobank. As previously described, we took non-NA median of multiple measurements across up to three time points (Tanigawa et al., 2019) . We focused on food intake, immune cell measurements, gross body measurements, behavioral phenotypes, and several other phenotypes (Table S1 ). We performed linear regression association analysis with v2.00a (20 Sep, 2017) for these 146 quantitative phenotypes. We performed quantile normalization for each phenotype (--pheno-quantile-normalize option), where we fit the linear model with covariates and transform the residuals to Normal distribution N(0, 1) while preserving the original rank in the residuals. We used the following covariates in our analysis: age, sex, array type, and the first four principal components, where array type is a binary variable that represents whether an individual was genotyped with UK Biobank Axiom Array or UK BiLEVE Axiom Array. For variants that were specific to one array, we did not use array as a covariate. We corrected p-values using the Benjamin-Yekutieli approach implemented in R's p.adjust. We considered associations with BY-corrected p-values less than 0.05 as significant which controls the false discovery rate at 5% (Yekutieli and Benjamini, 2001 ).
Binary phenotypes
Wd identified 129 binary phenotypes with at least 2,000 cases among the 337,205 white British subjects in the UK Biobank and performed logistic regression association analysis with Firthfallback using PLINK v2.00a (17 July 2017) . Firth-fallback is a hybrid algorithm which normally uses the logistic regression code described in (Hill et al., 2017) , but switches to a port of logistf() (https://cran.r-project.org/web/packages/logistf/index.html) in two cases: (1) one of the cells in the 2x2 allele count by case/control status contingency table is empty (2) logistic regression was attempted since all the contingency table cells were nonzero, but it failed to converge within the usual number of steps. We used the following covariates in our analysis: age, sex, array type, and the first four principal components, where array type is a binary variable that represents whether an individual was genotyped with UK Biobank Axiom Array or UK BiLEVE Axiom Array. For variants that were specific to one array, we did not use array as a covariate. We corrected p-values using the Benjamin-Yekutieli approach implemented in R's p.adjust. We considered associations with BY-corrected p-values less than 0.05 as significant which controls the false discovery rate at 5%.
Comparison to GWAS Catalog
We compared significant associations to the GWAS Catalog (Buniello et al., 2019) to determine whether the associations we identified had been previously reported. We downloaded the GWAS Catalog v1.0.2 on August 23, 2019. We matched phenotypes in the GWAS Catalog to our phenotypes using the FuzzyWuzzy python package and manually reviewed matches. We erred on the side of including similar phenotypes from the GWAS Catalog for matches that were not perfect. We then matched the associated variants to variants in the GWAS Catalog using rs identifiers and chromosome:position identifiers. In order to match variants using chromosome:position, we used dbSNP or UCSC LiftOver (https://genome.ucsc.edu/cgibin/hgLiftOver) to convert UK Biobank genotyping array coordinates in hg19 to GRCh38 coordinates to match with the GWAS Catalog.
We used LDlink (https://ldlink.nci.nih.gov/) (Machiela and Chanock, 2015) to identify variants in LD with the variants that we found associations for using the GBR British population from 1000 Genomes Phase 3 (Version 5). We matched these variants in LD with the associated variants to variants in the GWAS Catalog using rs identifiers and chromosome:position identifiers when rs identifiers failed.
B2AR Conditional Analyses
We fit a model for each of eosinophil counts, eosinophil percentage, monocyte percentage, and neutrophil count with the genotypes of rs1042713, rs1042714, and rs1800888 as independent variables. We included a constant and age, sex, array type, and the first four principal components as covariates for these models.
Coffee and Tea Intake Additivity Analysis
We fit two models for each of coffee and tea intake to test whether the associations were consistent with non-additive effects. We performed quantile normalization for each phenotype to transform the values to standard normal distribution. For the additive model, we encoded genotypes as 0,1,2 and included a single term for the effect of genotype on tea/coffee intake. For the genotypic model we included a term to indicate whether a subject was heterozygous and a separate term to indicate whether a subject was homozygous alternate. We included a constant and age, sex, array type, and the first four principal components as covariates for these regressions. Figure S1 . Distribution of PolyPhen-2 scores for (a) GPCR variants in ClinVar; (b) rare (MAF<1%) GPCR variants in gnomAD, (c) variants analyzed in this study that were not significantly associated with any phenotype, and (d) variants analyzed in this study that were significantly associated with at least one phenotype. (e) Distribution of family conservation scores for variants in class A GPCRs across the four groups of variants in a-d. The distribution of conservation scores is significantly different (Wilcoxon p<0.05) between the gnomAD Rare and ClinVar variants and between the ClinVar and UKB Not Associated variants. Figure S2 . Linkage disequilibrium in the GBR British population between rs72703203 (bold) and other CELSR2 variants reported in the GWAS Catalog as significantly associated with various lipid and cardiac phenotypes. Figure S3 . Linkage disequilibrium in the GBR British population between variants in GPR35 with significant associations in this study (bold) and variants reported in the GWAS Catalog. Figure S4 . Linkage disequilibrium in the GBR British population between variants in taste receptors associated with (a) tea intake on chromosome 7, (b) tea intake on chromosome 12, or (c) coffee intake on chromosome 12. Figure S5 . pEC50 for cAMP signaling, beta-arrestin-1 recruitment, and beta-arrestin-2 recruitment for four ADRB2 haplotypes upon stimulation with the endogenous ligands epinephrine (epi) and norepinephrine (norepi).
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Supplementary Tables   Table S1 . Phenotypes and GPCR genes and variants used for PheWAS. The "GPCR genes" tab contains 398 GPCR genes that we used to identify GPCR genetic variants. The "GPCR tested variants" tab contains the 268 variants that we tested in the PheWAS analysis. The "GPCR variant summary" tab shows the number of each variant type included in the pheWAS 21 analysis. The "Quantitative phenotypes" and "Binary phenotypes" tabs contain the phenotypes analyzed and the number of observations and cases, respectively. Table S2 . GPCR PheWAS results. Summary statistics for quantitative and binary associations with BY-adjusted p-value less than 0.05. Table S3 . GPCR variant annotations. Across-family conservation scores, GPCR functional region annotations, and PolyPhen-2 pathogenicity scores for GPCR variants assessed in this study, 86,601 rare GPCR variants from gnomAD (MAF<1%) and 318 GPCR variants reported in ClinVar. Table S4 . p-values from Tukey's test for differences in pEC50 for cAMP signaling, beta-arrestin-1 recruitment, and beta-arrestin-2 recruitment for four ADRB2 haplotypes upon stimulation with the endogenous ligands epinephrine (epi) and norepinephrine (norepi).
